Concepedia

Author

Angel L. Rivera

Yale University

Also Known As

Angel L. Rivera, Angel Rivera

11

Publications

1.2K

Citations

6

H-Index

35

Concepts

All Affiliations

Yale UniversityCornell UniversityUConn HealthYale Cancer CenterBristol-Myers Squibb (United States)
AL

About

Angel L. Rivera is an author at Yale University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

1.2K

2

Health Sciences

2

2

148

3

Social Sciences

2

2

47

4

Public Health

1

1

11

5

Biochemistry

1

1

36

Angel L. Rivera

×

6

Publications

1.2K

Citations

6

H-Index

YearCitations

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Scott Gettinger, Amit Mahajan,

The Lancet Oncology

2016

987

Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL).

Mario Sznol, Harriet M. Kluger, Margaret K. Callahan,

Journal of Clinical Oncology

2014

137

A1 adenosine receptor activation inhibits neurite process formation by rho kinase-mediated pathways

Sundararajah Thevananther, Angel L. Rivera, Scott A. Rivkees

Neuroreport

2001

36

Safety and activity of pembrolizumab in melanoma patients with untreated brain metastases.

Harriet M. Kluger, Sarah B. Goldberg, Mario Sznol,

Journal of Clinical Oncology

2015

34

Melanoma and immunotherapy bridge 2015

Vashisht Gopal Yennu Nanda, Weiyi Peng, Patrick Hwu,

Journal of Translational Medicine

2016

24

Condom knowledge, history of use, and attitudes among chemically addicted populations

Thomas H. Kramer, Jo Ann Mosely, Angel L. Rivera,

Journal of Substance Abuse Treatment

1991

11

Page 1